US Patent Issued to STEMBIOSYS on April 8 for "Amniotic fluid cell-derived extracellular matrix and uses thereof" (Texas Inventors)

ALEXANDRIA, Va., April 9 -- United States Patent no. 12,270,051, issued on April 8, was assigned to STEMBIOSYS INC. (San Antonio).

"Amniotic fluid cell-derived extracellular matrix and uses thereof" was invented by Travis Block (San Antonio), Edward S. Griffey (San Antonio) and Mary M. Navarro (San Antonio).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is a cell-derived extracellular matrix (ECM) derived in vitro from cells isolated from amniotic fluid, and methods of use for the isolation, maintenance, and proliferation of adherent cells including stem cells, as well as for the differentiation of stem cells."

The patent was filed on Oct. 13, 2021, under Application No. 17/500,408.

*For further i...